source
- Biotech reverse mergers rebound to highest level since 2021 as PIPEs flood market: reportReverse mergers have returned with a bang. More biotechs have taken the back door to the public markets so far in 2026 than in any full year since 2021, according to J.P. Morgan, with institutional…Fierce Biotech · 6h ago↗ source
- FDA approves Hibsago, first antisense therapy for chronic hepatitis BThe U.S. Food and Drug Administration has approved Hibsago (bepirovirsen) injection to be used alongside existing antiviral therapy for chronic hepatitis B virus infection in certain adults without…